Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Abuqbeitah, Mohammad; Demir, Mustafa; Kabasakal, Levent; Cavdar, Muhammed; Uslu-Besli, Mustafa; Yeyin, Nami; Razavikhosroshahi, Rabia; Sonmezoglu, Kerim

doi:10.1097/mnm.0000000000000900

Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer

Atıf İçin Kopyala

Abuqbeitah M. , Demir M., Kabasakal L. , Cavdar I. , Uslu-Besli L. , Yeyin N. , ...Daha Fazla

NUCLEAR MEDICINE COMMUNICATIONS, cilt.39, sa.11, ss.969-975, 2018 (SCI İndekslerine Giren Dergi)

Cilt numarası: 39 Konu: 11
Basım Tarihi: 2018
Doi Numarası: 10.1097/mnm.0000000000000900
Dergi Adı: NUCLEAR MEDICINE COMMUNICATIONS
Sayfa Sayıları: ss.969-975

Özet

Aim The development of reliable dosimetry models promotes the individualized therapy concept toward more success and less complications. This paper evaluates the traditional maximum empirical activity (250 mCi) and the benefit of joining two dosimetry approaches to optimize the therapeutic activity and radioiodine efficacy in metastatic differentiated thyroid cancer.